ARTICLE SUMMARY:
The most medtech policy documents came out of US FDA and China’s National Medical Products Administration in January, according to Pathways’ Document Depot. A look at a few important releases last month from around the globe.
Docs of the Month is a regular column highlighting key findings from Pathway Document Depot, a running inventory of global medtech regulatory and policy official documents, including rules, guidance documents, memos, white papers, and more from national authorities, non-governmental groups, and global organizations.
US FDA and China’s National Medical Products Administration (NMPA) each rolled out nine new or updated policy documents last month, making them the most prolific among the global agencies and organizations tracked by Document Depot.
